Morningstar desktop

What held investors’ attention in 2018? Stocks, stocks, stocks – top performing, top paying and ones to watch.

The top slot for the first half of the year went to an article revealing Morningstar analyst's picks for five companies across a range of sectors tipped to have good growth expectations over 2018.  

One of the biggest success stories included in the list was listed developer of medical devices for the treatment of sleep apnoea and other respiratory problems ResMed (ASX: RMD). The company, which started the year trading at $10.83, has risen to $15.78 – a jump of over 45 per cent.  

At the time of publication, Morningstar equity analyst Chris Kallos said an ageing population, coupled with accelerating obesity trends should drive significant growth in ResMed's target sleep apnoea market.

Other top articles this year included: 

Retirement remains in focus

For the latter half of 2018, news that Australians are underestimating how much money they'll need in retirement caught the attention of Morningstar readers.  

Research from global investment manager Schroders revealed that Australians are underestimating the amount of money they’ll need in retirement by up to 20 per cent.  

Other top articles included: 

2018 was a big year in video for Morningstar. We launched a new video series – 'How we invest your money' – which looks at the investment process of top fund managers and their team, including any broader macro-economic trends they’re tapping into and what they mean for retail investors.

We also explored a range of issues facing retail investing with experts from across the industry as part of our 'Ask the expert' series.  

Readers flocked to our video with Morningstar senior equity analyst Brian Han in May about why he remains optimistic about the outlook for Telstra, even as the telco's shares dropped further into the red.